Publications by authors named "Adam Crisp"

Claim this Profile
T
The changing landscape of data monitoring committees-Perspectives from regulators, members, and sponsors.
Amit Bhattacharyya, Paul Gallo, Adam Crisp, Lisa LaVange, Geert Molenberghs

Biom J· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical experiences of adopting assurance as a quantitative framework to support decision making in drug development.
Adam Crisp, Sam Miller, Douglas Thompson, Nicky Best

Pharm Stat· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
Stefan D Anker, Stefan Schroeder, Dan Atar, Jeroen J Bax, Claudio Ceconi, Adam Crisp

Eur J Heart Fail· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.
Stefan D Anker, Stefan Schroeder, Dan Atar, Jeroen J Bax, Claudio Ceconi, Adam Crisp

Eur J Heart Fail· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the limitations of permuted blocked randomization.
Adam Crisp

Stat Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinding in pharmaceutical clinical trials: An overview of points to consider.
Adam Crisp

Contemp Clin Trials· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.
Michelle L O'Donoghue, Ruchira Glaser, Philip E Aylward, Matthew A Cavender, Adam Crisp

Am Heart J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample size estimation for non-inferiority trials of time-to-event data.
Adam Crisp, Paula Curtis

Pharm Stat· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial.
Jim J Egan, Kevin B Carroll, Nizar Yonan, Ashley Woodcock, Adam Crisp

J Heart Lung Transplant· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.
Per Ljungman, Rafael de La Camara, Noel Milpied, Liisa Volin, Charlotte A Russell, Adam Crisp

Blood· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis